Chai Discovery Deep Dive: Turning Drug Design Into Software Engineering
Latent Space · youtube · 2026-08-12
Latent Space interviews Chai Discovery co-founder Matt McPartland and product lead Neil Patel on how AI is transforming pharma.
Key Insights & Facts:
- Pharma's Shift: Big pharma (Lilly, Pfizer, Novartis) abruptly started buying AI design tools this year instead of forcing AI-bio companies to build their own pipelines.
- Product Philosophy: The product looks more like SolidWorks than ChatGPT, and the team expects to throw most of it away eventually.
- Tech Breakthroughs: Chai-2 uses all-atom diffusion to co-design sequence and structure. A cryo-EM validation result was so accurate (0.33 Å) the team suspected the lab sent back their own file.
- Industry Vision: The CEO notes their real competitor is a mouse. The ultimate bottleneck isn't data, compute, or models, but the transition from science to engineering.
More from Apps
- Omnigent Lets You Run AI Agents and Approve Tool Calls Directly in Slack — matei_zaharia · 2026-08-12
- LiquidAI Launches LFM2.5-2.6B: An On-Device Agentic Model — JosephJacks_ · 2026-08-12
- GoodfireAI Launches Silico for Alignment Research at $1,000/Month — iamrobotbear · 2026-08-12
- Chrome's Multi-Layered Defenses Block Over 7B Abusive Notifications Daily — laparisa · 2026-08-12
- xAI Launches Grok Bot Beta: AI Teammates That Operate Tools — xiaosun86 · 2026-08-12
- Stability AI Launches Stable Layers: Decompose and Edit Any Image — multimodalart · 2026-08-12